Obesity was associated with improved overall survival (OS) after curative resection in patients with non-small cell lung cancer (NSCLC), particularly those who did not have low sk ...
Researchers have identified two microRNA that may predict which individuals with cancer are at elevated risk for ...
Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...
Young cancer patients have a 62% increased risk of dying if they live in a previously “redlined” residential area, ...
“Studies have shown that healthcare utilization at the end of life is high, and patients receive aggressive medical care that ...
Experts say two to three times weekly can be an optimal regimen, and 12 international researchers' work may inspire you to ...
Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
The FDA approved trastuzumab deruxtecan for adult patients with unresectable or metastatic HER2-low or HER2-ultralow breast ...
Young patients with cancer residing in historically redlined areas face a significantly higher risk of mortality, ...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...
As China’s population ages, few receive end-of-life care. Christians are helping the elderly face death with hope.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback